Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Big Easy Weight Loss vs FMmeds

Big Easy Weight Loss
Graded #59

Higher grade

vs+11.799999999999997
FMmeds
Graded #260

Lower grade

The verdict

Big Easy Weight Loss takes it — 75/100 to 63.2/100.

Big Easy Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Big Easy Weight Loss (joinbigeasy.com) is a New Orleans MD-run telehealth that ships compounded GLP-1 medication nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBig Easy Weight Loss +42
88
46
Dose & formulationEven
72
72
Clinical oversightBig Easy Weight Loss +8
78
70
Labs & monitoringFMmeds +1
52
53
FulfillmentFMmeds +7
90
97
Contract termsBig Easy Weight Loss +8
55
47
Big Easy Weight Loss · left barFMmeds · right bar

The numbers

MetricBig Easy Weight LossFMmeds
WeighScore75/10063.2/100
GradeCC
Scorecard rank#59#260
Semaglutide$133/mo (all doses, compounded)$225/mo (all doses, compounded)
Tirzepatide$166/mo (all doses, compounded)$265/mo (all doses, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Big Easy Weight Loss

Graded #59 · C

Strengths

  • Low pricing: about 133 dollars per month for semaglutide, 166 for tirzepatide
  • Site states it serves all 50 states with a 2 to 3 day pharmacy turnaround
  • Names its partner compounding pharmacies and a Chief Medical Officer

Where it loses points

  • Priced as 10 to 12-week packages rather than a simple monthly fee
  • New-patient pricing is promotional and may rise on renewal
FMmeds

Graded #260 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

Where it loses points

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard